The pandemic created significant challenges for life sciences commercial teams. Face-to-face interactions that traditionally were the mainstay of sales, market access, and patient services operations were not possible during stay-at-home orders, travel bans, and social distancing.
Moreover, accounts in different regions of the country experienced peak numbers of patients with COVID-19 at different times, requiring sales reps and other members of commercial teams to maintain agility while providing the pharmaceuticals and services that healthcare providers needed most.
This webinar, hosted by Brian Peters, VP of Sales and Marketing of Medexus, shares information on how commercial teams balanced compliance with remote work with new ways to interact with and engage their customers.
Panelists sharing their insights in this session are Rohit Vashisht, CEO and Co-Founder of WhizAI, Tanya Hill, Executive Director of Immunology Strategy for Mallinckrodt, Jason Morhart, Director of New Product Planning at Astellas, and John Alter, VP, Patient and Health Impact Lead, Hospital Business Unit at Pfizer,
Watch this on-demand webinar to learn:
- How commercial teams are adapting during the pandemic
- How teams can use data to streamline processes and increase visibility
- New tools and training that commercial teams require
- How teams are moving forward in the new normal